Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Mar;44(3):1163-1171.
doi: 10.1007/s10067-025-07312-3. Epub 2025 Jan 30.

Type D personality and social inhibition: drivers of cardiovascular risk and reduced physical activity in psoriatic arthritis

Affiliations

Type D personality and social inhibition: drivers of cardiovascular risk and reduced physical activity in psoriatic arthritis

Ayşegül Yetişir et al. Clin Rheumatol. 2025 Mar.

Abstract

Background: To evaluate the presence of type D personality and its association with metabolic syndrome (MetS), cardiovascular disease risk, and level of exercise in patients with psoriatic arthritis (PsA).

Material and method: This cross-sectional study included patients with PsA (n = 84) and healthy controls (n = 74). Sociodemographic data, laboratory parameters, and disease-related parameters were recorded. We evaluated the presence of type D personality with the total 14 items of the type D Personality Scale, the Framingham Risk Score (FRS) indicating 10-year cardiovascular disease risk as low, moderate, and high, the presence of MetS, and physical activity levels by the International Physical Activity Questionnaire-Short Form (IPAQ-SF).

Results: The median age of patients with PsA was 53.5 (17) years, 73.8% were female, and the disease duration was 7 (12) years. Compared to controls, patients with PsA exhibited higher FRS and increased frequency of MetS, type D personality, and its domains (social inhibition and negative affectivity) (p < 0.05 for all). Patients with type D personality had even a higher frequency of MetS and lower levels of moderate-intensity exercise than those without type D personality (p = 0.020 and p = 0.027). Patients with social inhibition had higher FRS, a higher frequency of MetS, and lower levels of moderate-intensity exercise (p < 0.05 for all) compared to those without social inhibition. MetS showed a significant positive correlation with social inhibition, waist circumference, and FRS (Spearman's rho were 0.244, 0.444, and 0.555, respectively), and a negative correlation with IPAQ-SF total metabolic equivalent (Spearman's rho was -0.214).

Conclusion: Patients with type D personality and social inhibition had a higher frequency of MetS and low levels of moderate-intensity exercise, whereas patients with social inhibition had a higher FRS. It is essential to assess PsA patients' cardiac risk factors, type D personality, and social inhibition, as well as provide exercise advice. Key Points •Psoriatic arthritis (PsA) is a prevelant rheumatologic disease that is frequently accompanied by comorbidities such as metabolic syndrome (MetS) and cardiovascular disease (CVD). •It is crucial to evaluate patients with PsA for CVD risk factors. •Patients with type D personality demonstrate lower engagement in moderate-intensity exercise and a higher frequency of MetS. Socially inhibited PsA patients showed elevated Framingham Risk Scores and MetS rates, as well as reduced levels of moderate-intensity exercise. •Beyond assessing cardiac risk factors, it is important to assess personality traits and offer tailored exercise recommendations for comprehensive PsA management.

Keywords: Framingham risk score; Metabolic syndrome; Psoriatic arthritis; Type D personality.

PubMed Disclaimer

Conflict of interest statement

Compliance with ethical standards. Disclosures: None.

References

    1. Cigolini C, Fattorini F, Gentileschi S, Terenzi R, Carli L (2022) Psoriatic arthritis: one year in review 2022. Clin Exp Rheumatol 40(9):1611–1619. 10.55563/clinexprheumatol/x3sfxe - PubMed
    1. Caso F, Chimenti MS, Navarini L, Ruscitti P, Peluso R, Girolimetto N, Del Puente A, Giacomelli R, Scarpa R, Costa L (2020) Metabolic syndrome and psoriatic arthritis: considerations for the clinician. Expert Rev Clin Immunol 16(4):409–420. 10.1080/1744666x.2020.1740593 - PubMed
    1. Fahed G, Aoun L, BouZerdan M, Allam S, BouZerdan M, Bouferraa Y, Assi HI (2022) Metabolic syndrome: updates on pathophysiology and management in 2021. Int J Mol Sci 23(2):786. 10.3390/ijms23020786 - PMC - PubMed
    1. Aljohani R (2022) Metabolic syndrome and its components in psoriatic arthritis. Open Access Rheumatol. 14:7–16. 10.2147/OARRR.S347797.10.2147/oarrr.s347797 - PMC - PubMed
    1. Piya MK (2021) Metabolic syndrome, rheumatoid and psoriatic arthritis: managing cardiovascular risk. Int J Rheum Dis 24(9):1103–1105. 10.1111/1756-185x.14197 - PubMed